Section2:References

From Assay Guidance Wiki

1. Sittampalam GS, Iversen PW, Boadt JA, Kahl SD, Bright S, Zock JM, Janzen WP and Lister MD: Design of Signal Windows in High Throughput Screening Assays for Drug Discovery. J Biomol Screen 1997;2:159-169.
2. Zhang J-H, Chung TDY, Oldenburg KR: A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J Biomol Screen 1999;4:67-73.
3. Taylor PB, Stewart FP, Dunnington DJ, Quinn ST, Schulz CK, Vaidya KS, Kurali E, Tonia RL, Xiong WC, Sherrill TP, Snider JS, Terpstra ND, and Hertzberg RP: Automated Assay Optimization with Integrated Statistics and Smart Robotics. J. Biomol Screen 2000;5:213-225.
4. Iversen PW, Eastwood BJ and Sittenpalam, GS: A Comparison of Assay Performance Measures in Screening Assays: Signal Window, Z’-Factor and Assay Variability Ratio. J of Biomol Screen, 2006;11:247-252.
5. Bland JM, Altman DG: Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;I:307-310.
6. Eastwood BJ, Farmen, MW, Iversen, PW, Craft, TJ, Smallwood, JK, Garbison, KE, Delapp, N, and Smith, GF: The Minimum Significant Ratio: A Statistical Parameter to Characterize the Reproducibility of Potency Estimates from Concentration-Response Assays and Estimation by Replicate-Experiment Studies. J Biomol Screen 2006;11:253-261.
7. Eastwood, BJ, Chesterfield, AK, Wolff MC, and Felder CC: Methods for the Design and Analysis of Replicate-Experiment Studies to Establish Assay Reproducibility and the Equivalence of Two Potency Assays, in Gad, S (ed): Drug Discovery Handbook, John Wiley and Sons, New York, 2005, 667-688.